DYSPORT Side Effects

7028220-0 | Deep Vein Thrombosis
on Oct 20, 2009 Male patient from SWEDEN , 55 years of age, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Dysport dosage: 470 Units In Right Arm And 100 Units In Rectus Femoris (570 Units, Single Cycle),. During the same period patient was treated with HERMOLEPSIN RETARD (CARBAMAZEPINE) (View Hermolepsin Retard (carbamazepine) Review and Hermolepsin Retard (carbamazepine) Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PERSANTIN DEPOT (DIPYRIDAMOLE) (View Persantin Depot (dipyridamole) Review and Persantin Depot (dipyridamole) Label ), BETOLVEX (CYANOCOBALAMIN) (View Betolvex (cyanocobalamin) Review and Betolvex (cyanocobalamin) Label ), SELOKEN ZOC (METOPROLOL SUCCINATE) (View Seloken Zoc (metoprolol Succinate) Review and Seloken Zoc (metoprolol Succinate) Label ), LASIX RETARD (TERBOLAN) (View Lasix Retard (terbolan) Review and Lasix Retard (terbolan) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized and became disabled.

7021539-9 | Eyelid Disorder, Off Label Use, Road Traffic Accident, Unevaluable Event
Patient was taking Dysport (View Usage). Patient had the following side effects: eyelid disorder, off label use, road traffic accident, unevaluable event on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 134.9 lb, was diagnosed with off label use, skin cosmetic procedure, skin wrinkling and. Dysport dosage: (single Cycle), Parenteral.

7021538-7 | Cerebellar Atrophy, Cerebral Infarction, Deafness Unilateral, Dysarthria, Facial Paresis, Gait Disturbance, Off Label Use
Adverse event was reported on Sep 13, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 60 Units (60 Units, Single Cycle), Intradermal) was diagnosed with skin wrinkling and. Location: UNITED STATES , 63 years of age, weighting 138.9 lb, After Dysport was administered, patient had the following side effects: cerebellar atrophy, cerebral infarction, deafness unilateral, dysarthria, facial paresis, gait disturbance, off label use. During the same period patient was treated with RESTYLANE L (HYALURONIC ACID) (View Restylane-l (hyaluronic Acid) Review and Restylane-l (hyaluronic Acid) Label ), PERCOCET (View Percocet Review and Percocet Label ), THYROID REPLACEMENT (THYROID HORMONES) (View Thyroid Replacement (thyroid Hormones) Review and Thyroid Replacement (thyroid Hormones) Label ), IMITREX (View Imitrex Review and Imitrex Label ), BUSPAR (View Buspar Review and Buspar Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ).

7010949-1 | Abdominal Pain Upper, Chest Pain, Dizziness, Dry Mouth, Fatigue, Feeling Abnormal, Gastric Disorder, Hypoaesthesia, Influenza Like Illness
on Sep 22, 2010 Female patient from UNITED STATES , 36 years of age, weighting 140.0 lb, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, chest pain (What is chest pain?), dizziness (What is dizziness?), dry mouth, fatigue, feeling abnormal, gastric disorder, hypoaesthesia, influenza like illness. Dysport dosage: 45 Units.


7008780-6 | Ecchymosis, Eyelid Ptosis
on Sep 06, 2010 Female patient from AUSTRALIA , 50 years of age, weighting 105.8 lb, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). Patient had the following side effects: ecchymosis, eyelid ptosis. Dysport dosage: 20 Units (20 Units, Single Cycle), Intradermal. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ALACASTRA (ZOLEDRONIC ACID) (View Alacastra (zoledronic Acid) Review and Alacastra (zoledronic Acid) Label ), CALTRATE (CALCIUM CARBONATE) (View Caltrate (calcium Carbonate) Review and Caltrate (calcium Carbonate) Label ).

6995137-7 | Injection Site Erythema, Injection Site Swelling, Off Label Use, Road Traffic Accident
Patient was taking Dysport (View Usage). After Dysport was administered, patient had the following side effects: injection site erythema, injection site swelling, off label use, road traffic accident on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 122.1 lb, was diagnosed with off label use, skin wrinkling and. Dysport dosage: 100 Units (total) (100 Units, Single Cycle), Parenteral.

6995131-6 | Injection Site Induration, Injection Site Swelling
Adverse event was reported on Sep 03, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 50 Units (50 Units, Single Cycle), Intramuscular) was diagnosed with skin wrinkling and. Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: injection site induration, injection site swelling.

6992585-6 | Chest Discomfort, Dyspnoea, Wheezing
on Sep 06, 2010 Female patient from UNITED KINGDOM , 41 years of age, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, wheezing. Dysport dosage: 1000 Units (1000 Units,single Cycle) Intramuscular, (,single Cycle) Intramuscular; Single Cycle.

6992337-7 | Off Label Use, Rash
on Sep 02, 2010 Female patient from CZECH REPUBLIC , 57 years of age, was diagnosed with off label use, skin cosmetic procedure and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: off label use, rash (What is rash?). Dysport dosage: 27 Units (27 Units, Single Cycle), Intramuscular.

6956881-0 | Deafness Transitory, Deafness Unilateral, Migraine, Nerve Injury, Sudden Hearing Loss, Tinnitus
Patient was taking Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: deafness transitory, deafness unilateral, migraine (What is migraine?), nerve injury, sudden hearing loss, tinnitus (What is tinnitus?) on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 140.0 lb, was diagnosed with off label use, skin wrinkling and. Dysport dosage: 60 Units (60 Units, Single Cycle). During the same period patient was treated with RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), VAGIFEM (View Vagifem Review and Vagifem Label ).

6956251-5 | Abasia, Dysphagia, Nervous System Disorder, Respiratory Disorder
Adverse event was reported on Aug 13, 2010 by a Male patient taking Dysport (View Usage) (Dosage: 10 Units (10 Units,single Cycle)) was diagnosed with diplopia, off label use and. Location: BELGIUM , 22 years of age, weighting 165.3 lb, Patient had the following side effects: abasia, dysphagia, nervous system disorder, respiratory disorder. During the same period patient was treated with TEMODAL (View Temodal Review and Temodal Label ). Patient was hospitalized.

6945526-1 | Injection Site Erythema, Injection Site Mass, Injection Site Swelling, Road Traffic Accident
on Aug 05, 2010 Female patient from UNITED STATES , 48 years of age, weighting 122.1 lb, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: injection site erythema, injection site mass, injection site swelling, road traffic accident. Dysport dosage: 100 Units (total) 100 Units, Single Cycle, Parenteral.

6924146-9 | Injection Site Pustule, Injection Site Rash, Throat Tightness, Tremor
on Aug 12, 2010 Female patient from UNITED STATES , 39 years of age, weighting 129.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pustule, injection site rash, throat tightness, tremor. Dysport dosage: 1 Vial. Patient was hospitalized.

6918185-1 | Dizziness, Headache, Injection Site Pain, Keratitis Bacterial, Ulcerative Keratitis
Patient was taking Dysport (View Usage). Patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), injection site pain, keratitis bacterial, ulcerative keratitis on Jul 23, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 119.0 lb, was diagnosed with skin wrinkling and. Dysport dosage: (,single Cycle), Intramuscular.

6917250-2 | Cerebellar Atrophy, Cerebellar Infarction, Deafness Unilateral, Dysarthria, Facial Paresis, Gait Disturbance, Glioma, Metastases To Central Nervous System
Adverse event was reported on Jul 22, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 60 Units (60 Units, Sincle Cycle) Intradermal) was diagnosed with skin wrinkling and. Location: UNITED STATES , 63 years of age, weighting 138.9 lb, After Dysport was administered, patient had the following side effects: cerebellar atrophy, cerebellar infarction, deafness unilateral, dysarthria, facial paresis, gait disturbance, glioma, metastases to central nervous system. During the same period patient was treated with RESTYLANE L (HYALURONIC ACID) (View Restylane-l (hyaluronic Acid) Review and Restylane-l (hyaluronic Acid) Label ), PERCOCET (View Percocet Review and Percocet Label ), THYROID REPLACEMENT (THYROID HORMONES) (View Thyroid Replacement (thyroid Hormones) Review and Thyroid Replacement (thyroid Hormones) Label ), IMITREX (View Imitrex Review and Imitrex Label ), BUSPAR (View Buspar Review and Buspar Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ).

6917244-7 | Injection Site Swelling, Road Traffic Accident, Swelling Face
on Jul 24, 2010 Female patient from UNITED STATES , 48 years of age, weighting 122.1 lb, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: injection site swelling, road traffic accident, swelling face. Dysport dosage: Single Cycle, Parenteral.

6917160-0 | Eyelid Ptosis, Off Label Use, Periorbital Oedema
on Jul 21, 2010 Female patient from AUSTRALIA , 54 years of age, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). Patient had the following side effects: eyelid ptosis, off label use, periorbital oedema. Dysport dosage: 140 Units (140 Units, Single Cycle),. During the same period patient was treated with INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

6917147-8 | Fatigue, Headache, Vision Blurred
Patient was taking Dysport (View Usage). After Dysport was administered, patient had the following side effects: fatigue, headache (What is headache?), vision blurred on Aug 09, 2010 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 135.0 lb, . Dysport dosage: .

6906229-2 | Abdominal Discomfort, Asthenia, Influenza Like Illness, Muscular Weakness, Myalgia, Pain, Rash
Adverse event was reported on Aug 03, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 500 Units 1) was diagnosed with migraine (What is migraine?), musculoskeletal pain, neck pain and. Location: UNITED STATES , weighting 155.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, asthenia, influenza like illness, muscular weakness, myalgia, pain (What is pain?), rash (What is rash?).

6896584-4 | Dysphagia, Palatal Disorder, Paralysis
on Jul 16, 2010 Female patient from UNITED KINGDOM , 46 years of age, weighting 154.3 lb, was diagnosed with myoclonus, palatal disorder and was treated with Dysport (View Usage). Patient had the following side effects: dysphagia, palatal disorder, paralysis (What is paralysis?). Dysport dosage: 30 Units, 1 In 3 M, Intramuscular.

6877180-1 | Blister, Rash Erythematous, Urticaria
on Jul 27, 2010 Female patient from UNITED STATES , 41 years of age, weighting 111.0 lb, was diagnosed with facial operation, skin wrinkling and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: blister, rash erythematous, urticaria. Dysport dosage: 85 Units.

6874714-8 | Deafness Unilateral, Facial Paresis, Gait Disturbance, Marital Problem
Patient was taking Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: deafness unilateral, facial paresis, gait disturbance, marital problem on Jul 07, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 138.9 lb, was diagnosed with off label use, skin wrinkling and. Dysport dosage: 60 Units (60 Units,single Cycle), Intradermal. During the same period patient was treated with RESTYLANE L (HYALURONIC ACID) (View Restylane-l (hyaluronic Acid) Review and Restylane-l (hyaluronic Acid) Label ), PERCOCET (View Percocet Review and Percocet Label ), THYROID REPLACEMERLT (THYROID HORMONES) (View Thyroid Replacemerlt (thyroid Hormones) Review and Thyroid Replacemerlt (thyroid Hormones) Label ), IMITREX (SUMATRIPTIAN) (View Imitrex (sumatriptian) Review and Imitrex (sumatriptian) Label ), BUSPAR (View Buspar Review and Buspar Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ).

6874645-3 | Deafness Unilateral, Migraine, Nerve Injury, Tinnitus
Adverse event was reported on Jul 07, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 60 Units (60 Units, Single Cycle),) was diagnosed with off label use, skin wrinkling and. Location: UNITED STATES , 55 years of age, weighting 140.0 lb, Patient had the following side effects: deafness unilateral, migraine (What is migraine?), nerve injury, tinnitus (What is tinnitus?). During the same period patient was treated with RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), VAGIFEM (View Vagifem Review and Vagifem Label ).

6874596-4 | Cardiac Disorder, Heart Transplant
on Jul 12, 2010 Male patient from UNITED KINGDOM , 20 years of age, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: cardiac disorder, heart transplant (What is heart transplant?). Dysport dosage: 800 - 1000 Units (1000 Units, 1 In 3 M), Intramuscular 08/20/2008 - Interrupted. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FERROUS SULPHINE (FERROUS SULFATE) (View Ferrous Sulphine (ferrous Sulfate) Review and Ferrous Sulphine (ferrous Sulfate) Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6836938-5 | Fall, Head Injury
on Jun 29, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), head injury. Dysport dosage: . During the same period patient was treated with BOTOX (View Botox Review and Botox Label ), TRAODONE (TRAZODONE) (View Traodone (trazodone) Review and Traodone (trazodone) Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), ANTIDEPRESSANT (ANTIDEPRESSANTS) (View Antidepressant (antidepressants) Review and Antidepressant (antidepressants) Label ).

6836937-3 | Deafness Unilateral, Migraine, Nerve Injury, Tinnitus
Patient was taking Dysport (View Usage). Patient had the following side effects: deafness unilateral, migraine (What is migraine?), nerve injury, tinnitus (What is tinnitus?) on Jun 25, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 140.0 lb, was diagnosed with skin wrinkling and. Dysport dosage: . During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ), RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), VAGIFEM (View Vagifem Review and Vagifem Label ).

6819992-6 | Blood Pressure Inadequately Controlled, Circumoral Oedema, Dry Mouth, Dysarthria, Dysphonia, Eating Disorder, Facial Palsy, Hypertension, Mouth Injury
Adverse event was reported on Jun 16, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 100 Units (100 Units, Single Cycle) ,intramuscular) was diagnosed with off label use, skin wrinkling and. Location: UNITED STATES , 67 years of age, weighting 142.0 lb, After Dysport was administered, patient had the following side effects: blood pressure inadequately controlled, circumoral oedema, dry mouth, dysarthria, dysphonia, eating disorder (What is eating disorder?), facial palsy, hypertension, mouth injury. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ZOCOR (View Zocor Review and Zocor Label ), AMBIEN (View Ambien Review and Ambien Label ).

6819852-0 |
on Jun 24, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). . Dysport dosage: . During the same period patient was treated with BOTOX (View Botox Review and Botox Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), ANIDEPRESSANT (ANTIDEPRESSSANTS) (View Anidepressant (antidepresssants) Review and Anidepressant (antidepresssants) Label ).

6818759-2 | Activities Of Daily Living Impaired, Condition Aggravated, Depressed Mood, Diplopia, Disturbance In Attention, Dry Eye, Dyskinesia, Dysphagia, Eye Pain
on Jun 16, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). Patient had the following side effects: activities of daily living impaired, condition aggravated, depressed mood, diplopia, disturbance in attention, dry eye, dyskinesia, dysphagia, eye pain. Dysport dosage: 900 Units (900 Units, Single Cycle Therapies 1 Per Year), Intramuscular. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), MYOLASTAN (TETRAZEPAM) (View Myolastan (tetrazepam) Review and Myolastan (tetrazepam) Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (View Kardegic (acetylsalicylate Lysine) Review and Kardegic (acetylsalicylate Lysine) Label ), LIORESAL (View Lioresal Review and Lioresal Label ), MEPRONIZINE (MEPRONIZINE) (View Mepronizine (mepronizine) Review and Mepronizine (mepronizine) Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6818734-8 | Asthenia, Choking, Disorientation, Dizziness, Dysphagia, Dyspnoea Exertional
Patient was taking Dysport (View Usage). After Dysport was administered, patient had the following side effects: asthenia, choking (What is choking?), disorientation, dizziness (What is dizziness?), dysphagia, dyspnoea exertional on Jun 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 47 years of age, was diagnosed with muscle spasticity and. Dysport dosage: See Image. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

6818732-4 | Muscular Weakness
Adverse event was reported on Jun 23, 2010 by a Male patient taking Dysport (View Usage) (Dosage: 900 Units (900 Units, Single), Intramuscular) was diagnosed with muscle spasticity and. Location: AUSTRALIA , 72 years of age, Patient experienced the following unwanted or unexpected effects: muscular weakness. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COLOXYL (DOCUSATE SODIUM) (View Coloxyl (docusate Sodium) Review and Coloxyl (docusate Sodium) Label ), SENNOKOT (SENNA ALEANDRINA) (View Sennokot (senna Aleandrina) Review and Sennokot (senna Aleandrina) Label ).

6788817-X | Chest Discomfort, Dizziness, Dry Mouth, Dysphagia, Dyspnoea, Facial Palsy, Fatigue, Feeling Abnormal, Glare
on Jun 10, 2010 Female patient from UNITED STATES , 51 years of age, weighting 114.0 lb, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). Patient had the following side effects: chest discomfort, dizziness (What is dizziness?), dry mouth, dysphagia, dyspnoea, facial palsy, fatigue, feeling abnormal, glare. Dysport dosage: 100 Units (100 Units,single Cycle). During the same period patient was treated with RESTYLANE(HYALURONIC ACID) (View Restylane(hyaluronic Acid) Review and Restylane(hyaluronic Acid) Label ), RADIESSE (CALCIUM COMPOUNDS) (View Radiesse (calcium Compounds) Review and Radiesse (calcium Compounds) Label ), MULTIVITAMIN (MULTIVITAMIN /00831701/) (View Multivitamin (multivitamin /00831701/) Review and Multivitamin (multivitamin /00831701/) Label ). Patient was hospitalized.

6787254-1 | Activities Of Daily Living Impaired, Condition Aggravated, Depressed Mood, Diplopia, Disturbance In Attention, Dry Eye, Dyskinesia, Dysphagia, Eye Pain
on Jun 07, 2010 Male patient from FRANCE , 56 years of age, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: activities of daily living impaired, condition aggravated, depressed mood, diplopia, disturbance in attention, dry eye, dyskinesia, dysphagia, eye pain. Dysport dosage: See Image. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), MYOLASTAN (TETRAZEPAM) (View Myolastan (tetrazepam) Review and Myolastan (tetrazepam) Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (View Kardegic (acetylsalicylate Lysine) Review and Kardegic (acetylsalicylate Lysine) Label ), LIORESAL (View Lioresal Review and Lioresal Label ), MEPRONIZINE (MEPRONIZINE) (View Mepronizine (mepronizine) Review and Mepronizine (mepronizine) Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6786894-3 | Abasia, Dysphagia, Respiratory Disorder
Patient was taking Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, dysphagia, respiratory disorder on Jun 08, 2010 from BELGIUM Additional patient health information: Male patient , 22 years of age, was diagnosed with diplopia, off label use and. Dysport dosage: 10 Units (10 Units, Single Cycle). During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ), TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

6782497-5 | Dysphagia, Hypersensitivity, Hypoaesthesia, Hypoaesthesia Facial, Swollen Tongue
Adverse event was reported on Jun 01, 2010 by a Male patient taking Dysport (View Usage) (Dosage: 100 Units (100 Units Single Cycle)) was diagnosed with off label use, skin wrinkling and. Location: UNITED STATES , 44 years of age, weighting 160.1 lb, Patient had the following side effects: dysphagia, hypersensitivity, hypoaesthesia, hypoaesthesia facial, swollen tongue. During the same period patient was treated with . (View . Review and . Label ), RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), RADIESSE (CALCIUM COMPOUNDS) (View Radiesse (calcium Compounds) Review and Radiesse (calcium Compounds) Label ), MULTIVITAMIN (MULTIVITAMIN) (View Multivitamin (multivitamin) Review and Multivitamin (multivitamin) Label ).

6782496-3 | Anxiety, Chest Discomfort, Dizziness, Dry Mouth, Dysphagia, Dyspnoea, Eyelid Ptosis, Fatigue, Feeling Abnormal
on Jun 03, 2010 Female patient from UNITED STATES , 51 years of age, weighting 114.0 lb, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: anxiety (What is anxiety?), chest discomfort, dizziness (What is dizziness?), dry mouth, dysphagia, dyspnoea, eyelid ptosis, fatigue, feeling abnormal. Dysport dosage: 100 Units (100 Units, Single). During the same period patient was treated with . (View . Review and . Label ), RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), RADIESSE (CALCIUM COMPUNDS) (View Radiesse (calcium Compunds) Review and Radiesse (calcium Compunds) Label ), MULTIVITAMIN (MULTIVITAMIN) (View Multivitamin (multivitamin) Review and Multivitamin (multivitamin) Label ). Patient was hospitalized.

6773544-5 | Abnormal Sensation In Eye, Anxiety, Chest Discomfort, Dizziness, Dry Mouth, Dysphagia, Dyspnoea, Eyelid Ptosis, Fatigue
on May 27, 2010 Female patient from UNITED STATES , 51 years of age, weighting 114.0 lb, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, anxiety (What is anxiety?), chest discomfort, dizziness (What is dizziness?), dry mouth, dysphagia, dyspnoea, eyelid ptosis, fatigue. Dysport dosage: (single Cycle),. During the same period patient was treated with RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), RADIESSE (CALCIUM COMPOUNDS) (View Radiesse (calcium Compounds) Review and Radiesse (calcium Compounds) Label ), MULTIVITAMIN (MULTIVITAMIN /00831701/) (View Multivitamin (multivitamin /00831701/) Review and Multivitamin (multivitamin /00831701/) Label ). Patient was hospitalized.

6770835-9 | Asthenia, Bronchitis, Eye Disorder, Fatigue, Malaise, Nasal Discomfort, Productive Cough, Pyrexia, Rash
Patient was taking Dysport (View Usage). Patient had the following side effects: asthenia, bronchitis (What is bronchitis?), eye disorder, fatigue, malaise, nasal discomfort, productive cough, pyrexia, rash (What is rash?) on Jun 14, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with skin wrinkling and. Dysport dosage: 50 Units.

6760941-7 | Cerebrovascular Accident, Dry Mouth, Dysphonia, Feeding Disorder, Hypertension, Lip Swelling, Swollen Tongue
Adverse event was reported on May 27, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 100 Units (100 Units, Single Cycle), Intramuscular) was diagnosed with off label use, skin wrinkling and. Location: UNITED STATES , 67 years of age, weighting 142.0 lb, After Dysport was administered, patient had the following side effects: cerebrovascular accident, dry mouth, dysphonia, feeding disorder, hypertension, lip swelling, swollen tongue. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ZOCOR (View Zocor Review and Zocor Label ), AMBIEN (View Ambien Review and Ambien Label ).

6760937-5 | Chest Discomfort, Dry Mouth, Dysphagia, Dyspnoea, Eyelid Ptosis, Fatigue, Feeling Abnormal, Headache, Off Label Use
on May 22, 2010 Female patient from UNITED STATES , 51 years of age, weighting 114.0 lb, was diagnosed with off label use, skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, dry mouth, dysphagia, dyspnoea, eyelid ptosis, fatigue, feeling abnormal, headache (What is headache?), off label use. Dysport dosage: Single Cycle. During the same period patient was treated with RESTYLANE (HYALURONIC ACID) (View Restylane (hyaluronic Acid) Review and Restylane (hyaluronic Acid) Label ), RADIESSE (CALCIUM COMPOUNDS) (View Radiesse (calcium Compounds) Review and Radiesse (calcium Compounds) Label ), MULTIVITAMIN (MULTIVITAMIN) (View Multivitamin (multivitamin) Review and Multivitamin (multivitamin) Label ). Patient was hospitalized.

6760923-5 | Arthralgia, Muscular Weakness
on May 24, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). Patient had the following side effects: arthralgia, muscular weakness. Dysport dosage: 60 Units (60 Units, Single Cycle), Intramuscular.

6760714-5 | Anxiety, Bladder Irritation, Burning Sensation, Chest Discomfort, Disorientation, Dizziness, Dry Mouth, Dysarthria, Dysphagia
Patient was taking Dysport (View Usage). After Dysport was administered, patient had the following side effects: anxiety (What is anxiety?), bladder irritation, burning sensation, chest discomfort, disorientation, dizziness (What is dizziness?), dry mouth, dysarthria, dysphagia on Jun 07, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 138.9 lb, was diagnosed with skin wrinkling and. Dysport dosage: 45 Units.

6760189-6 | Aspiration, Dysphagia, Posture Abnormal, Speech Disorder
Adverse event was reported on May 20, 2010 by a Male patient taking Dysport (View Usage) (Dosage: 300 Units (300 Units, Single Cycle)) was diagnosed with drooling and. Location: FRANCE , child 8 years of age, Patient experienced the following unwanted or unexpected effects: aspiration, dysphagia, posture abnormal, speech disorder.

6760188-4 | Arthropathy, Pain In Extremity, Pyrexia
on May 23, 2010 Male patient from SAUDI ARABIA , child 12 years of age, weighting 44.09 lb, was diagnosed with muscle spasticity and was treated with Dysport (View Usage). Patient had the following side effects: arthropathy, pain in extremity, pyrexia. Dysport dosage: 200 Units (200 Units, Single Cycle), Intramuscular. During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ).

6759877-7 | Dysphagia, Dyspnoea, Product Reconstitution Issue
on May 25, 2010 Female patient from UNITED STATES , 41 years of age, weighting 132.3 lb, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: dysphagia, dyspnoea, product reconstitution issue. Dysport dosage: 38 Units (38 Units, Single Cycle), Intradermal. During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ).

6753684-7 | Biopsy, Dysphagia, Hypoaesthesia, Swollen Tongue
Patient was taking Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy, dysphagia, hypoaesthesia, swollen tongue on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 44 years of age, weighting 160.1 lb, was diagnosed with skin wrinkling and. Dysport dosage: 60 Units (60 Units, Single Cycle), Intramuscular. During the same period patient was treated with SYNTHORID (LEVOTHYROXINE SODIUM) (View Synthorid (levothyroxine Sodium) Review and Synthorid (levothyroxine Sodium) Label ).

6744236-3 | Dyspnoea, Wheezing
Adverse event was reported on May 13, 2010 by a Female patient taking Dysport (View Usage) (Dosage: 1000 Units (1000 Units,single Cycle), Intramuscular) was diagnosed with muscle spasticity and. Location: UNITED KINGDOM , 41 years of age, Patient had the following side effects: dyspnoea, wheezing.

6742855-1 | Arthralgia, Arthropathy, Muscular Weakness, Musculoskeletal Pain
on May 10, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). After Dysport was administered, patient had the following side effects: arthralgia, arthropathy, muscular weakness, musculoskeletal pain. Dysport dosage: 60 Units (60 Units,single Cycle), Intramuscular. During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ).

6742854-X | Asthenia, Chest Pain, Dysphagia, Insomnia, Lethargy, Oropharyngeal Pain, Upper Respiratory Tract Infection
on May 13, 2010 Female patient from UNITED STATES , 37 years of age, was diagnosed with skin wrinkling and was treated with Dysport (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chest pain (What is chest pain?), dysphagia, insomnia, lethargy, oropharyngeal pain, upper respiratory tract infection. Dysport dosage: 40 Units (40 Units,single Cycle), Intramuscular. During the same period patient was treated with BOTULINUM TOXIN TYPE A (View Botulinum Toxin Type A Review and Botulinum Toxin Type A Label ), VICODIN (View Vicodin Review and Vicodin Label ), XANAX (View Xanax Review and Xanax Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6737567-4 | Asthenia, Dizziness, Headache, Impaired Driving Ability, Malaise, Nausea, Nervous System Disorder, Sinusitis, Syncope
Patient was taking Dysport (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), headache (What is headache?), impaired driving ability, malaise, nausea (What is nausea?), nervous system disorder, sinusitis (What is sinusitis?), syncope on May 21, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 151.0 lb, was diagnosed with skin cosmetic procedure and. Dysport dosage: .